419 related articles for article (PubMed ID: 29093509)
21. Gut Microbiota Aberration in Patients of Systemic Sclerosis and Bleomycin-Induced Mice Model.
Tang J; Zhou X; Wu X; Lin S; Ming B; Zhong J; Wang B; Dong L
Front Cell Infect Microbiol; 2021; 11():647201. PubMed ID: 34123867
[TBL] [Abstract][Full Text] [Related]
22. A review and roadmap of the skin, lung and gut microbiota in systemic sclerosis.
Teaw S; Hinchcliff M; Cheng M
Rheumatology (Oxford); 2021 Dec; 60(12):5498-5508. PubMed ID: 33734316
[TBL] [Abstract][Full Text] [Related]
23. Gut microbiota profile in healthy Indonesians.
Rahayu ES; Utami T; Mariyatun M; Hasan PN; Kamil RZ; Setyawan RH; Pamungkaningtyas FH; Harahap IA; Wiryohanjoyo DV; Pramesi PC; Cahyanto MN; Sujaya IN; Juffrie M
World J Gastroenterol; 2019 Mar; 25(12):1478-1491. PubMed ID: 30948911
[TBL] [Abstract][Full Text] [Related]
24. Potential Role of Gut Microbiota in ALS Pathogenesis and Possible Novel Therapeutic Strategies.
Mazzini L; Mogna L; De Marchi F; Amoruso A; Pane M; Aloisio I; Cionci NB; Gaggìa F; Lucenti A; Bersano E; Cantello R; Di Gioia D; Mogna G
J Clin Gastroenterol; 2018; 52 Suppl 1, Proceedings from the 9th Probiotics, Prebiotics and New Foods, Nutraceuticals and Botanicals for Nutrition & Human and Microbiota Health Meeting, held in Rome, Italy from September 10 to 12, 2017():S68-S70. PubMed ID: 29782468
[TBL] [Abstract][Full Text] [Related]
25. Towards a disease-associated common trait of gut microbiota dysbiosis: The pivotal role of Akkermansia muciniphila.
Lopetuso LR; Quagliariello A; Schiavoni M; Petito V; Russo A; Reddel S; Del Chierico F; Ianiro G; Scaldaferri F; Neri M; Cammarota G; Putignani L; Gasbarrini A
Dig Liver Dis; 2020 Sep; 52(9):1002-1010. PubMed ID: 32576522
[TBL] [Abstract][Full Text] [Related]
26. Cause or effect? Interpreting emerging evidence for dysbiosis in systemic sclerosis.
Denton CP; Murray C
Arthritis Res Ther; 2019 Mar; 21(1):81. PubMed ID: 30917857
[TBL] [Abstract][Full Text] [Related]
27. Dysbiosis and compositional alterations with aging in the gut microbiota of patients with heart failure.
Kamo T; Akazawa H; Suda W; Saga-Kamo A; Shimizu Y; Yagi H; Liu Q; Nomura S; Naito AT; Takeda N; Harada M; Toko H; Kumagai H; Ikeda Y; Takimoto E; Suzuki JI; Honda K; Morita H; Hattori M; Komuro I
PLoS One; 2017; 12(3):e0174099. PubMed ID: 28328981
[TBL] [Abstract][Full Text] [Related]
28. Fecal microbiota transplantation in systemic sclerosis: A double-blind, placebo-controlled randomized pilot trial.
Fretheim H; Chung BK; Didriksen H; Bækkevold ES; Midtvedt Ø; Brunborg C; Holm K; Valeur J; Tennøe AH; Garen T; Midtvedt T; Trøseid M; Zarè H; Lund MB; Hov JR; Lundin KEA; Molberg Ø; Hoffmann-Vold AM
PLoS One; 2020; 15(5):e0232739. PubMed ID: 32437393
[TBL] [Abstract][Full Text] [Related]
29. Alteration of gut microbiota-associated epitopes in children with autism spectrum disorders.
Wang M; Zhou J; He F; Cai C; Wang H; Wang Y; Lin Y; Rong H; Cheng G; Xu R; Zhou W
Brain Behav Immun; 2019 Jan; 75():192-199. PubMed ID: 30394313
[TBL] [Abstract][Full Text] [Related]
30. Alterations of the Gut Microbiome in Hypertension.
Yan Q; Gu Y; Li X; Yang W; Jia L; Chen C; Han X; Huang Y; Zhao L; Li P; Fang Z; Zhou J; Guan X; Ding Y; Wang S; Khan M; Xin Y; Li S; Ma Y
Front Cell Infect Microbiol; 2017; 7():381. PubMed ID: 28884091
[No Abstract] [Full Text] [Related]
31. Genes, emotions and gut microbiota: The next frontier for the gastroenterologist.
Panduro A; Rivera-Iñiguez I; Sepulveda-Villegas M; Roman S
World J Gastroenterol; 2017 May; 23(17):3030-3042. PubMed ID: 28533660
[TBL] [Abstract][Full Text] [Related]
32. Systemic sclerosis and the gut.
Butt S; Emmanuel A
Expert Rev Gastroenterol Hepatol; 2013 May; 7(4):331-9. PubMed ID: 23639091
[TBL] [Abstract][Full Text] [Related]
33. Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls.
Chen J; Chia N; Kalari KR; Yao JZ; Novotna M; Paz Soldan MM; Luckey DH; Marietta EV; Jeraldo PR; Chen X; Weinshenker BG; Rodriguez M; Kantarci OH; Nelson H; Murray JA; Mangalam AK
Sci Rep; 2016 Jun; 6():28484. PubMed ID: 27346372
[TBL] [Abstract][Full Text] [Related]
34. Gastrointestinal involvement in systemic sclerosis: pathogenesis, assessment and treatment.
Volkmann ER; McMahan Z
Curr Opin Rheumatol; 2022 Nov; 34(6):328-336. PubMed ID: 35993874
[TBL] [Abstract][Full Text] [Related]
35. Long-term benefit of Microbiota Transfer Therapy on autism symptoms and gut microbiota.
Kang DW; Adams JB; Coleman DM; Pollard EL; Maldonado J; McDonough-Means S; Caporaso JG; Krajmalnik-Brown R
Sci Rep; 2019 Apr; 9(1):5821. PubMed ID: 30967657
[TBL] [Abstract][Full Text] [Related]
36. Altered gut microbiota in Rett syndrome.
Strati F; Cavalieri D; Albanese D; De Felice C; Donati C; Hayek J; Jousson O; Leoncini S; Pindo M; Renzi D; Rizzetto L; Stefanini I; Calabrò A; De Filippo C
Microbiome; 2016 Jul; 4(1):41. PubMed ID: 27473171
[TBL] [Abstract][Full Text] [Related]
37. Gastrointestinal manifestation of systemic sclerosis--thickening of the upper gastrointestinal wall detected by endoscopic ultrasound is a valid sign.
Zuber-Jerger I; Müller A; Kullmann F; Gelbmann CM; Endlicher E; Müller-Ladner U; Fleck M
Rheumatology (Oxford); 2010 Feb; 49(2):368-72. PubMed ID: 20008473
[TBL] [Abstract][Full Text] [Related]
38. Gastrointestinal motility disorder assessment in systemic sclerosis.
Savarino E; Mei F; Parodi A; Ghio M; Furnari M; Gentile A; Berdini M; Di Sario A; Bendia E; Bonazzi P; Scarpellini E; Laterza L; Savarino V; Gasbarrini A
Rheumatology (Oxford); 2013 Jun; 52(6):1095-100. PubMed ID: 23382360
[TBL] [Abstract][Full Text] [Related]
39. Managing gastrointestinal manifestations in systemic sclerosis, a mechanistic approach.
Kaniecki T; Hughes M; McMahan Z
Expert Rev Clin Immunol; 2024 Jun; 20(6):603-622. PubMed ID: 38406978
[TBL] [Abstract][Full Text] [Related]
40. How to Manipulate the Microbiota: Fecal Microbiota Transplantation.
Fuentes S; de Vos WM
Adv Exp Med Biol; 2016; 902():143-53. PubMed ID: 27161356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
